CDK4/6 inhibition promotes CD8+ T cell expansion through tumor‐macrophage crosstalk by activating HIF‐1α and enhancing MIF‐CD44/CD74 signaling. This reprograms TAMs to boost MHC‐I antigen presentation, and CDK4/6 inhibitor‐trained M1 TAM supernatant therapy synergizes with low‐dose PD‐1 blockade to restore antitumor immunity.
Lin He +17 more
wiley +1 more source
Evaluation of RECIST v1.1 for predicting overall survival in sarcoma patients with pulmonary metastasis. [PDF]
Gold L +11 more
europepmc +1 more source
Perioperative risk stratification after resection of brain metastases: internal development and validation of the dominant lesion surgery score in a 20-year single-center cohort. [PDF]
Aydın HA, Keskin E, Kalaycı M.
europepmc +1 more source
Using the Systemic Inflammatory Response Index and the Prognostic Nutritional Index in Predicting Subsequent Bone Metastases in Patients with Non-Small Cell Lung Cancer. [PDF]
Wang P, Yan X, Yan G, Li D, Ma L.
europepmc +1 more source
Sclerodermoid cutaneous metastases secondary to prostate adenocarcinoma. [PDF]
De Jong K +9 more
europepmc +1 more source
Perioperative psycho-behavioral stress promotes cancer metastasis beyond the impact of surgery: Neuroendocrine and tumor molecular mediating mechanisms. [PDF]
Shvalbo BB +8 more
europepmc +1 more source
Chinese expert consensus on magnetic resonance-guided focused ultrasound surgery for painful bone metastases. [PDF]
Fan X +8 more
europepmc +1 more source
Related searches:

